FindTrial
Sign In

To know and compare the level of a body chemical i.e., cytokines(Interleukines-17) in different type of arthritis

IL-17 levels in Ankylosing Spondylitis, Reactive Arthritis and Undifferentiated Arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052731
Enrollment
17
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M450- Ankylosing spondylitis of multiplesites in spine Health Condition 2: M129- Arthropathy, unspecified Health Condition 3: M468- Other specified inflammatory spondylopathies

Interventions

Control Intervention1: Nil: Nil

Sponsors

Principal Investigator
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed case/previously diagnosed case of Ankylosing Spondylitis, Reactive Arthritis and Undifferentiated Arthritis 2. Age more than 18 years 3. Those who give consent for participation

Exclusion criteria

Exclusion criteria: 1.Pregnant women and lactating mother 2.Associated with other overlapping inflammatory arthritis and connective tissue disease 3. Active infection (e.g., Hepatitis B/C, HIV & others) 4. Malignancy

Design outcomes

Primary

MeasureTime frame
Difference in IL-17 level among the patients of AS, ReA, UATimepoint: at baseline—

Secondary

MeasureTime frame
Correlation of IL-17 with disease activity of AS, ReA, UATimepoint: at baseline—

Countries

India

Contacts

Public ContactJhasaketan Meher

AIIMS, Raipur

drjhasaketanmeher@aiimsraipur.edu.in9810780839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026